Cargando…
COVID‐19 and the gain of function debates: Improving biosafety measures requires a more precise definition of which experiments would raise safety concerns
The COVID‐19 pandemic has rekindled debates about gain‐of‐function experiments. This is an opportunity to clearly define safety risks and appropriate countermeasures.[Image: see text]
Autores principales: | Warmbrod, Kelsey Lane, Montague, Michael G, Gronvall, Gigi Kwik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490979/ https://www.ncbi.nlm.nih.gov/pubmed/34477287 http://dx.doi.org/10.15252/embr.202153739 |
Ejemplares similares
-
The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate
por: Rozo, Michelle, et al.
Publicado: (2015) -
National-Level Biosafety Norms Needed for Dual-Use Research
por: Gronvall, Gigi Kwik
Publicado: (2014) -
A Biosafety Agenda to Spur Biotechnology Development and Prevent Accidents
por: Gronvall, Gigi Kwik
Publicado: (2017) -
Addressing the Gap in International Norms for Biosafety
por: Gronvall, Gigi Kwik, et al.
Publicado: (2015) -
Improving U.S. Biosafety and Biosecurity: Revisiting Recommendations from the Federal Experts Security Advisory Panel and the Fast Track Action Committee on Select Agent Regulations
por: Haines, Clint A., et al.
Publicado: (2023)